Physician profile
Sultan Salem
NPI 1235324278
$758.75
in general payments reported to CMS, 2019-2025
12 companies · $50.80 in 2025
The $50.80 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $159 · 2021: $278 · 2022: $15.29 · 2023: $54.27 · 2024: $70.03 · 2025: $50.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $231.68 | 2021 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2020 | |
| Nobel Biocare USA | $95.16 | 2019-2023 | Nobelactive |
| Ss White Burs LLC | $72.71 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $68.26 | 2019-2025 | Arestin |
| Biolase, INC. | $45.92 | 2021 | |
| Align Technology, INC. | $40.75 | 2024-2025 | Invisalign |
| Dentsply Sirona INC | $22.13 | 2024 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Solventum Corporation | $16.23 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Filtek, 3m Scotchbond |
| Voco America INC. | $15.29 | 2022 | |
| Philips North America LLC | $14.73 | 2025 | Oral Health Care Undivided |
| Ultradent Products INC | $10.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sultan Salem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.